Compare SGMO & VTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGMO | VTN |
|---|---|---|
| Founded | 1995 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.1M | 161.4M |
| IPO Year | 2000 | N/A |
| Metric | SGMO | VTN |
|---|---|---|
| Price | $0.50 | $11.62 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.71 | N/A |
| AVG Volume (30 Days) | ★ 9.3M | 41.7K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | ★ $32,875,000.00 | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $67.06 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $8.49 |
| 52 Week High | $2.84 | $10.81 |
| Indicator | SGMO | VTN |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 77.81 |
| Support Level | $0.42 | $11.38 |
| Resistance Level | $0.55 | $11.49 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 67.23 | 91.53 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Invesco Trust For Investment Grade New York Municipals is a diversified closed-end management investment company. Its objective is to provide common shareholders with a high level of current income exempt from federal as well as from New York State and New York City income taxes, consistent with preservation of capital.